Scientists launch new trial for long COVID treatment

Scientists at Scripps Research recently launched a new clinical trial that will test if a repurposed GLP-1 drug, tirzepatide, can provide possible relief for long COVID symptoms.Monday on Midday Edition, we sit down with Dr. Eric Topol to hear more about the trial and the state of long COVID research and treatment today.Guest:Dr. Eric Topol, executive vice president, Scripps Research Translational InstituteResources: Long COVID Treatment Trial — Scripps Research

Episode metadata supplied by the publisher feed · Published Nov 10, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Scientists launch new trial for long COVID treatment

0:00 14:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of KPBS Midday Edition?

This episode is 14 minutes long.

When was this KPBS Midday Edition episode published?

This episode was published on November 10, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this KPBS Midday Edition episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!